Mechanism of the Cytotoxic Interaction between ET-18-OMe and Heat

  • K. Fujiwara
  • C. Fletcher
  • E. J. Modest
  • C. A. Wallen
Part of the Developments in Oncology book series (DION, volume 67)


Ether lipid analogues of platelet-activating factor have been shown to kill cancer cells either alone or in combination with other cancer chemotherapeutic agents (1–3). Recently, we have shown that one of the ether lipid analogues, ET-18-OMe1, and 44°C hyperthermia interact supra-additively to kill BG-1 human ovarian carcinoma cells at concentration ≤0.5 μM of ET-18-OMe and additively at higher concentrations (0.5 to 2.0 μM) of ET-18-OMe (4). The mechanism of this cytotoxic interaction of ET-18-OMe and heat is presently unknown. In this study, we examine flow cytometrically two parameters, cell cycle distribution and nuclear protein content, that are altered after heat treatment to determine if they are involved in the mechanism governing the interaction of heat and ET-18-OMe.


Cell Cycle Distribution Ether Lipid Kill Cancer Cell Propidium Iodide Fluorescence Cancer Chemotherapeutic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Modest, E.J., Daniel, L.W., Wykle, R.L., Berens, M.E., Piantadosi, C, Surles, J.R., and Morris Natschke, S. In: New Avenues in Developmental Cancer Chemotherapy (Eds. K.R. Harrap and T.A. Connors), Academic Press, London, 1987, pp. 387–400.Google Scholar
  2. 2.
    Berdel, W.E., Andressen, R., and Munder, P.G. In: Phospholipids and Cellular Regulation. (Ed. J.F. Kuo), CRC Press, Vol. 2, Boca Raton, 1985, pp. 41–73.Google Scholar
  3. 3.
    Noseda, A., Berens, M.E., White, J.G. and Modest, E.J. Cancer Res. 48:1788–1719, 1988.PubMedGoogle Scholar
  4. 4.
    Fujiwara, K, Modest, E.J., Welander, C.E., and Wallen, C.A. Cancer Res. 49:6285–6289,1989.PubMedGoogle Scholar
  5. 5.
    Geisinger, K.R., Kute, T.E., Pettenati, M.J., Welander, C.E., Dennard, Y., Collins, L.A., and Berens, M.E. Cancer, 63:280–288, 1989.PubMedCrossRefGoogle Scholar
  6. 6.
    Roti Roti, J.L., Higashikubo, R., Blair, O.C. and Uygur, N. Cytometry. 3:91–96, 1982.CrossRefGoogle Scholar
  7. 7.
    Roos, G. and Berdel, W.E. Leukemia Res. 10:195–202, 1986.CrossRefGoogle Scholar
  8. 8.
    Fujiwara, K, Modest, E.J., and Wallen, C.A. Proc. AACR 30:578, 1989.Google Scholar
  9. 9.
    Roti Roti, J.L., and Winward, R.T. Radiat. Res. 74:159–169, 1978.CrossRefGoogle Scholar
  10. 10.
    Tomasovic, S.P., Turner, G.N. and Dewey, W.L. Radiat. Res. 73:535–552. 1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Wallen, C.A. and Landis, M. Int. J. Hyperthermia 1990, 6:87–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Kampinga, H.H., Turkel-Uygur, N., Roti Roti, J.L., and Konnings, AW.T. Radiat. Res. 117:511–522, 1989.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • K. Fujiwara
    • 1
  • C. Fletcher
    • 1
  • E. J. Modest
    • 1
  • C. A. Wallen
    • 1
  1. 1.Departments of Radiology and BiochemistryBowman Gray School of Medicine of Wake Forest UniversityWinston-SalemUSA

Personalised recommendations